Key result
Perioperative adverse cardiac events (PACE) within 30 days after non-cardiac surgery were significantly associated with a 33% increased risk of one-year mortality (HR 1.33) compared to patients without PACE.
Why the study?
Perioperative adverse cardiac events (PACE) are associated with long-term mortality, but clinical evidence remains limited.
Does the occurrence of perioperative adverse cardiac events (PACE) increase long-term mortality in adult patients undergoing non-cardiac surgery?
Cohort (n=277,787)
Yes
Does the occurrence of perioperative adverse cardiac events (PACE) increase long-term mortality in adult patients undergoing non-cardiac surgery?
Hazard Ratio: 1.33 (95% CI 1.1–1.6)
Absolute Event Rate: 6% vs 4.4%
p-value: p=0.005
Perioperative adverse cardiac events within 30 days of non-cardiac surgery are significantly associated with increased one-year and three-year mortality, particularly in older patients and those undergoing high-risk or emergency surgeries.
PACE signals elevated long-term mortality risk after surgery; extends observational evidence but leaves causal impact and interventions open.
BACKGROUND: Perioperative adverse cardiac events (PACE), a composite of myocardial infarction, coronary revascularization, congestive heart failure, arrhythmic attack, acute pulmonary embolism, cardiac arrest, and stroke during 30-day postoperative period, is associated with long-term mortality, but with limited clinical evidence. We compared long-term mortality with PACE using data from nationwide multicenter electronic health records. METHODS: Data from 7 hospitals, converted to Observational Medical Outcomes Partnership Common Data Model, were used. We extracted records of 277,787 adult patients over 18 years old undergoing non-cardiac surgery for the first time at the hospital and had medical records for more than 180 days before surgery. We performed propensity score matching and then an aggregated meta‑analysis. RESULTS: After 1:4 propensity score matching, 7,970 patients with PACE and 28,807 patients without PACE were matched. The meta‑analysis showed that PACE was associated with higher one-year mortality risk (hazard ratio [HR]: 1.33, 95% CI [1.10, 1.60], P = 0.005) and higher three-year mortality (HR: 1.18, 95% CI [1.01, 1.38], P = 0.038). In subgroup analysis, the risk of one-year mortality by PACE became greater with higher-risk surgical procedures (HR: 1.20, 95% CI [1.04, 1.39], P = 0.020 for low-risk surgery; HR: 1.69, 95% CI [1.45, 1.96], P < 0.001 for intermediate-risk; and HR: 2.38, 95% CI [1.47, 3.86], P = 0.034 for high-risk). CONCLUSIONS: A nationwide multicenter study showed that PACE was significantly associated with increased one-year mortality. This association was stronger in high-risk surgery, older, male, and chronic kidney disease subgroups. Further studies to improve mortality associated with PACE are needed.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2023) conducted a cohort in Non-cardiac surgery (n=277,787). Perioperative adverse cardiac events (PACE) vs. Patients without PACE was evaluated on One-year mortality (HR 1.33, 95% CI 1.10, 1.60, p=0.005). Perioperative adverse cardiac events (PACE) within 30 days after non-cardiac surgery were significantly associated with a 33% increased risk of one-year mortality (HR 1.33) compared to patients without PACE.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: